Jiangsu Jibeier Pharmaceutical Co., Ltd.
SSE:688566.SS
28.15 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 201.801 | 253.327 | 209.546 | 235.943 | 191.363 | 243.958 | 198.163 | 253.471 | 165.341 | 228.161 | 169.359 | 118.389 | 138.822 | 142.868 | 116.023 | 130.728 | 120.075 | 163.01 | 159.892 | 126.541 | 116.531 | 139.563 | 146.939 | 133.417 | 122.6 | 113.245 |
| Cost of Revenue
| 21.038 | 27.772 | 22.587 | 25.436 | 20.433 | 26.56 | 22.139 | 26.708 | 19.747 | 24.985 | 19.396 | 15.784 | 16.003 | 17.831 | 14.924 | 15.752 | 13.613 | 17.499 | 17.928 | 14.278 | 13.163 | 16.197 | 16.729 | 16.233 | 14.729 | 64.167 |
| Gross Profit
| 180.763 | 225.555 | 186.958 | 210.508 | 170.931 | 217.398 | 176.024 | 226.762 | 145.595 | 203.176 | 149.962 | 102.605 | 122.819 | 125.037 | 101.099 | 114.976 | 106.462 | 145.51 | 141.964 | 112.263 | 103.368 | 123.366 | 130.21 | 117.184 | 107.871 | 49.078 |
| Gross Profit Ratio
| 0.896 | 0.89 | 0.892 | 0.892 | 0.893 | 0.891 | 0.888 | 0.895 | 0.881 | 0.89 | 0.885 | 0.867 | 0.885 | 0.875 | 0.871 | 0.88 | 0.887 | 0.893 | 0.888 | 0.887 | 0.887 | 0.884 | 0.886 | 0.878 | 0.88 | 0.433 |
| Reseach & Development Expenses
| 7.835 | 7.488 | 13.767 | 7.478 | 9.696 | 13.675 | 13.5 | 20.064 | 8.534 | 13.346 | 12.648 | 22.157 | 7.029 | 5.469 | 6.835 | 11.514 | 5.464 | 10.082 | 7.103 | 11.474 | 4.888 | 8.238 | 12.083 | 6.217 | 4.621 | 0 |
| General & Administrative Expenses
| 14.372 | -30.303 | 38.933 | -8.057 | 14.03 | -26.008 | 34.235 | -6.3 | 14.144 | -23.848 | 32.08 | -4.531 | 10.783 | -20.996 | 27.781 | -5.138 | 8.707 | -18.729 | 11.623 | -3.585 | 7.012 | -19.078 | 10.163 | -3.696 | 7.339 | 0 |
| Selling & Marketing Expenses
| 99.408 | -24.282 | 161.366 | 109.192 | 87.658 | 121.148 | 80.48 | 120.827 | 79.417 | 97.066 | 81.129 | 61.034 | 71.683 | 72.292 | 59.667 | 66.259 | 61.944 | 79.413 | 83.373 | 65.004 | 59.857 | 63.496 | 77.212 | 70.812 | 63.533 | 0 |
| SG&A
| 113.78 | -54.585 | 110.741 | 125.854 | 100.86 | 95.14 | 114.716 | 114.528 | 93.562 | 73.218 | 113.21 | 56.503 | 82.466 | 51.295 | 87.448 | 61.121 | 70.651 | 60.684 | 94.996 | 61.419 | 66.87 | 44.418 | 87.375 | 67.115 | 70.872 | 0 |
| Other Expenses
| 1.989 | 218.907 | -88.131 | -0.324 | -0.145 | -171.939 | -0.134 | -0.154 | 1.032 | 39.323 | -18.651 | 16.113 | 1.394 | -0.212 | -0.459 | -0.028 | -0.374 | -0.722 | -0.2 | -0.995 | -0.043 | -0.114 | -0.135 | 0.047 | -0.001 | -29.772 |
| Operating Expenses
| 123.604 | 171.811 | 125.935 | 133.332 | 110.557 | 171.939 | 110.396 | 157.567 | 103.128 | 125.887 | 107.207 | 94.773 | 90.89 | 91.973 | 76.584 | 92.159 | 76.53 | 102.411 | 104.721 | 88.422 | 73.295 | 80.675 | 101.682 | 89.194 | 76.729 | -29.772 |
| Operating Income
| 57.159 | 53.745 | 61.023 | 77.175 | 60.374 | 72.019 | 69.08 | 67.914 | 40.125 | 87.05 | 43.368 | 13.443 | 32.539 | 45.197 | 25.524 | 31.509 | 31.404 | 58.912 | 38.405 | 23.969 | 29.273 | 44.607 | 29.082 | 26.823 | 29.544 | 19.305 |
| Operating Income Ratio
| 0.283 | 0.212 | 0.291 | 0.327 | 0.315 | 0.295 | 0.349 | 0.268 | 0.243 | 0.382 | 0.256 | 0.114 | 0.234 | 0.316 | 0.22 | 0.241 | 0.262 | 0.361 | 0.24 | 0.189 | 0.251 | 0.32 | 0.198 | 0.201 | 0.241 | 0.17 |
| Total Other Income Expenses Net
| -0.112 | -0.728 | -0.104 | -0.324 | -0.145 | -1.186 | -0.134 | -0.154 | -0.162 | -0.545 | -1.169 | -0.13 | -0.023 | -0.212 | -0.459 | -0.028 | -0.374 | -0.722 | -0.2 | -1.065 | -0.043 | -0.114 | -0.135 | -0.022 | -0.001 | -0.158 |
| Income Before Tax
| 57.047 | 53.017 | 60.919 | 80.927 | 60.893 | 70.833 | 68.946 | 67.76 | 39.963 | 86.505 | 42.199 | 13.313 | 32.517 | 44.985 | 25.065 | 31.481 | 31.031 | 58.19 | 38.204 | 22.904 | 29.231 | 44.494 | 28.947 | 26.801 | 29.543 | 19.147 |
| Income Before Tax Ratio
| 0.283 | 0.209 | 0.291 | 0.343 | 0.318 | 0.29 | 0.348 | 0.267 | 0.242 | 0.379 | 0.249 | 0.112 | 0.234 | 0.315 | 0.216 | 0.241 | 0.258 | 0.357 | 0.239 | 0.181 | 0.251 | 0.319 | 0.197 | 0.201 | 0.241 | 0.169 |
| Income Tax Expense
| 7.6 | 8.354 | 8.445 | 10.526 | 7.061 | 6.83 | 10.228 | 9.597 | 2.056 | 11.184 | 5.158 | -0.115 | 4.045 | 6.459 | 4.561 | 2.929 | 4.267 | 7.279 | 4.833 | 2.613 | 3.946 | 5.848 | 3.329 | 4.445 | 3.379 | 283.233 |
| Net Income
| 49.53 | 44.764 | 52.558 | 69.493 | 52.513 | 64.019 | 58.805 | 58.253 | 38.011 | 75.411 | 37.145 | 13.527 | 28.584 | 38.653 | 20.599 | 28.67 | 26.979 | 50.896 | 33.322 | 20.397 | 25.103 | 38.788 | 25.582 | 22.441 | 26.104 | 15.441 |
| Net Income Ratio
| 0.245 | 0.177 | 0.251 | 0.295 | 0.274 | 0.262 | 0.297 | 0.23 | 0.23 | 0.331 | 0.219 | 0.114 | 0.206 | 0.271 | 0.178 | 0.219 | 0.225 | 0.312 | 0.208 | 0.161 | 0.215 | 0.278 | 0.174 | 0.168 | 0.213 | 0.136 |
| EPS
| 0.25 | 0.228 | 0.26 | 0.35 | 0.28 | 0.33 | 0.31 | 0.31 | 0.2 | 0.4 | 0.2 | 0.072 | 0.15 | 0.21 | 0.11 | 0.15 | 0.14 | 0.27 | 0.18 | 0.15 | 0.18 | 0.27 | 0.18 | 0.16 | 0.19 | 0.11 |
| EPS Diluted
| 0.25 | 0.228 | 0.26 | 0.35 | 0.28 | 0.32 | 0.31 | 0.31 | 0.2 | 0.4 | 0.19 | 0.071 | 0.15 | 0.21 | 0.11 | 0.15 | 0.14 | 0.27 | 0.18 | 0.15 | 0.18 | 0.27 | 0.18 | 0.16 | 0.19 | 0.11 |
| EBITDA
| 57.119 | 53.059 | 60.926 | 83.875 | 63.149 | 75.377 | 73.384 | 66.959 | 43.703 | 91.76 | 47.094 | 14.073 | 37.594 | 51.793 | 28.711 | 34.007 | 34.524 | 43.099 | 41.914 | 26.252 | 32.468 | 46.093 | 31.587 | 31.122 | 31.142 | -260.222 |
| EBITDA Ratio
| 0.283 | 0.209 | 0.291 | 0.355 | 0.33 | 0.309 | 0.37 | 0.264 | 0.264 | 0.402 | 0.278 | 0.119 | 0.271 | 0.363 | 0.247 | 0.26 | 0.288 | 0.264 | 0.262 | 0.207 | 0.279 | 0.33 | 0.215 | 0.233 | 0.254 | -2.298 |